3,720,000 Shares Adamis Pharmaceuticals Corporation PURCHASE AGREEMENTPurchase Agreement • December 17th, 2013 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,720,000 shares (the “Firm Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriter an option to purchase up to 558,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
